These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 9931125)

  • 1. Effect of ACE inhibitor on DOCA-salt- and aortic coarctation-induced hypertension in mice: do kinin B2 receptors play a role?
    Rhaleb NE; Peng H; Alfie ME; Shesely EG; Carretero OA
    Hypertension; 1999 Jan; 33(1 Pt 2):329-34. PubMed ID: 9931125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of angiotensin-converting enzyme inhibitor and angiotensin type 1 receptor antagonist in deoxycorticosterone acetate-salt hypertensive mice lacking Ren-2 gene.
    Peng H; Carretero OA; Alfie ME; Masura JA; Rhaleb NE
    Hypertension; 2001 Mar; 37(3):974-80. PubMed ID: 11244026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diminished cardioprotective response to inhibition of angiotensin-converting enzyme and angiotensin II type 1 receptor in B(2) kinin receptor gene knockout mice.
    Yang XP; Liu YH; Mehta D; Cavasin MA; Shesely E; Xu J; Liu F; Carretero OA
    Circ Res; 2001 May; 88(10):1072-9. PubMed ID: 11375278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of kinins and nitric oxide in the antihypertrophic effect of ramipril.
    Rhaleb NE; Yang XP; Scicli AG; Carretero OA
    Hypertension; 1994 Jun; 23(6 Pt 2):865-8. PubMed ID: 7515854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinin-mediated antihypertensive effect of captopril in deoxycorticosterone acetate-salt hypertension.
    Chen K; Zhang X; Dunham EW; Zimmerman BG
    Hypertension; 1996 Jan; 27(1):85-9. PubMed ID: 8591894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renovascular hypertension in bradykinin B2-receptor knockout mice.
    Madeddu P; Milia AF; Salis MB; Gaspa L; Gross W; Lippoldt A; Emanueli C
    Hypertension; 1998 Sep; 32(3):503-9. PubMed ID: 9740617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A specific B2-bradykinin receptor antagonist HOE 140 abolishes the antihypertrophic effect of ramipril.
    Linz W; Schölkens BA
    Br J Pharmacol; 1992 Apr; 105(4):771-2. PubMed ID: 1324047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible protective effects of kinins and converting enzyme inhibitors in cardiovascular tissues.
    Nolly H; Miatello R; Damiani MT; Abate CD
    Immunopharmacology; 1997 Jun; 36(2-3):185-91. PubMed ID: 9228545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of high salt intake in mutant mice lacking bradykinin-B2 receptors.
    Alfie ME; Sigmon DH; Pomposiello SI; Carretero OA
    Hypertension; 1997 Jan; 29(1 Pt 2):483-7. PubMed ID: 9039146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors.
    Liu YH; Yang XP; Sharov VG; Nass O; Sabbah HN; Peterson E; Carretero OA
    J Clin Invest; 1997 Apr; 99(8):1926-35. PubMed ID: 9109437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The kallikrein-kinin system as a regulator of cardiovascular and renal function.
    Rhaleb NE; Yang XP; Carretero OA
    Compr Physiol; 2011 Apr; 1(2):971-93. PubMed ID: 23737209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors.
    Linz W; Wiemer G; Gohlke P; Unger T; Schölkens BA
    Pharmacol Rev; 1995 Mar; 47(1):25-49. PubMed ID: 7784479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinin contribution to chronic antihypertensive actions of ACE-inhibitors in hypertensive rats.
    Bao G; Gohlke P; Unger T
    Agents Actions Suppl; 1992; 38 ( Pt 2)():423-30. PubMed ID: 1334342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Chronic Blockade of the Kallikrein-Kinin System on the Development of Hypertension in Rats.
    Rhaleb NE; Yang XP; Nanba M; Shesely EG; Carretero OA
    Hypertension; 2001 Jan; 37(1):121-128. PubMed ID: 11208766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salt-sensitive hypertension in bradykinin B2 receptor knockout mice.
    Alfie ME; Yang XP; Hess F; Carretero OA
    Biochem Biophys Res Commun; 1996 Jul; 224(3):625-30. PubMed ID: 8713099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of SA7060, a novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme, on deoxycorticosterone acetate-salt-induced hypertension in rats.
    Kuro T; Okahara A; Nose M; Ikuse T; Matsumura Y
    Biol Pharm Bull; 2000 Jul; 23(7):820-5. PubMed ID: 10919359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arterial responses to bradykinin after ramipril therapy in experimental hypertension.
    Hutri-Kähönen N; Pörsti I; Wu X; Tolvanen JP; Sallinen K; Kähönen M
    Pharmacol Toxicol; 1997 Oct; 81(4):190-6. PubMed ID: 9353850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual ACE and NEP inhibitor MDL-100,240 prevents and regresses severe angiotensin II-dependent hypertension partially through bradykinin type 2 receptor.
    Rossi GP; Cavallin M; Rizzoni D; Bova S; Mazzocchi G; Agabiti-Rosei E; Nussdorfer GG; Pessina AC
    J Hypertens; 2002 Jul; 20(7):1451-9. PubMed ID: 12131544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of aortic atrial natriuretic factor and angiotensinogen in experimental hypertension.
    Ogawa T; Linz W; Schölkens BA; de Bold AJ
    J Cardiovasc Pharmacol; 1998 Dec; 32(6):1001-8. PubMed ID: 9869508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of bradykinin in chronic antihypertensive actions of ramipril in different hypertension models.
    Bao G; Gohlke P; Unger T
    J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S96-9. PubMed ID: 1282637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.